Professor Martyn Caplin is a distinguished Professor of Gastroenterology and Tumour Neuroendocrinology at the Royal Free Hospital and University College London. He has been a pivotal figure in the field since his appointment, leading the Royal Free Hospital European Neuroendocrine Tumor Society Centre of Excellence.

Prof Caplin spearheads scientific and clinical research programmes focused on rare cancers at University College London. His expertise and leadership were recognised when he was elected Chairman of the European Neuroendocrine Tumor Society from 2014 to 2016, and he continues to serve on its advisory board. Additionally, he is a founder and Past-Chairman of the UK & Ireland Neuroendocrine Tumour Society and has been honoured with a Lifetime Achievement Award for his contributions to clinical leadership and research in rare cancers.

Prof Caplin's roles extend to being a member of the National Cancer Research Institute (NCRI) and a Past-Chairman of the rare cancer group. He currently chairs the European Union Reference Network for Rare Cancers, specifically for neuroendocrine tumours.

Previously, Prof Caplin served as the clinical lead for “NHS Evidence” in Gastroenterology and Liver diseases under NICE. He has a keen interest in the relationship between diet and disease, having published extensively on the impact of diet and food supplements on health.

His areas of expertise include general gastroenterology problems, including complex cases, endoscopy procedures such as gastroscopy and colonoscopy, diet-associated gastrointestinal symptoms and diseases, and neuroendocrine tumours.

Prof Caplin's dedication to advancing medical knowledge and patient care in gastroenterology and neuroendocrine tumours makes him a leading specialist in his field.